期刊文献+

羟考酮复合丙泊酚在无痛取卵术中的应用 被引量:8

Application of oxycodone hydrochloride combined with propofol in painless oocyte retrieval
下载PDF
导出
摘要 目的观察羟考酮复合丙泊酚用于无痛取卵术的镇痛效果及安全性。方法选择我院门诊行无痛取卵术患者100例,年龄20~40岁,体重45~75kg,ASAⅠ或Ⅱ级,按随机数字表法分为两组:羟考酮复合丙泊酚组(A组)和单纯丙泊酚组(B组),每组50例。A组缓慢静脉注射羟考酮0.1mg/kg(生理盐水稀释至5ml),B组静脉注射等量生理盐水,5min后均静脉注射丙泊酚1.5~2mg/kg。苏醒时间、手术操作时间、丙泊酚用量、术后30min VAS评分和不良反应发生情况。结果术中丙泊酚用量A组为(121±18)mg,明显少于B组的(165±21)mg(P〈0.05)。术后VAS评分A组为(1.5±0.8)分,明显低于B组的(3.2±0.7)分(P〈0.05)。体动反应A组有8例(16%),明显少于B组的30例(60%)(P〈0.05)。结论羟考酮复合丙泊酚可安全用于无痛取卵术并能减少丙泊酚用量,减轻术后疼痛。 Objective To investigate the effect and safety of oxycodone hydrochloride combined with propofol for patients underwent painless oocyte etrieval.Methods Patients who underwent painless oocyte retrieval 100 cases,falling into ASA grade Ⅰ or Ⅱ catergory,aged 20 to 40years old,weighing 45-75 kg,were randomly divided into group A and group B,50 patients in each group,according to random number tables.Group A were injected slowly oxycodone hydrochloride 0.1mg/kg(diluted to 5ml of normal saline),and group B saline.All patients were injected propofol 1.5-2mg/kg after 5 min.Recovery time,operation time,propofol consumption,post-operative 30 min VAS scores and side effects were recorded accordingly.Results The propofol consumption(121±18)mg in group A was significantly less than that in group B(165±21)mg(P〈0.05).The VAS scores(1.5±0.8)score in group A was lower than that in group B(3.2±0.7)score(P〈0.05).The movement response occurred in 8(16%)and 30(60%)patients in group A and group B(P〈0.05),respectively.Conclusion Oxycodone hydrochloride combined with propofol can be safely used for painless oocyte retrieval and reduce propofol consumption,relieving postoperative pain.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2016年第10期957-959,共3页 Journal of Clinical Anesthesiology
关键词 羟考酮 丙泊酚 无痛取卵术 Oxycodone hydrochloride Propofol Painless oocyte retrieval
  • 相关文献

参考文献10

  • 1Wicke V, Weigert M, Danninger B,et al. Painfulness oftransvaginal follicle aspiration for oocyte retrieval in in-vitro-fertilization. Zentralbl Gynakol, 2000, 122(3) : 169-174.
  • 2Kwan I,Bhattacharya S,Knox F,et al. Pain relief forwomen undergoing oocyte retrieval assisted reproduction. Co-chrane Database Syst Rev, 2013,8(1) :CD004829.
  • 3Staahl C,Christrup LL,Andersen SD,et al. A comparativestudy of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain, 2006,123 (1-2):28-36.
  • 4胡建,许建峰,刘耿,洪敏,陶林,章壮云,徐亚杰,斯妍娜,鲍红光.不同剂量羟考酮术前用药对腹腔镜胆囊切除术后疼痛及炎症细胞因子的影响[J].临床麻醉学杂志,2015,31(10):941-944. 被引量:71
  • 5Ludwig AK,Glawatz M,Griesinger G, et al. Perioperativeand post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of〉1 000 oocyteretrievals. Hum Reprod, 2006,21(12) : 3235-3240.
  • 6Andreassen TN,Klepstad P, Davies A,et al Is oxycodoneefficacy reflected in serum concentrations? A multicenter,cross-sectional study in 456 adult cancer patients. J PainSymptom Manage, 2012,43 (4) : 694-705.
  • 7Koch S, Ahlburg P, Spangsberg N, et al. Oxycodone vs. fen tanyl in the treatment of early post-operative pain after lapa roscopic cholecystectomy: a randomised double-blind study Aeta Anaesthesiol Seand, 2008, 52(6) :845-850.
  • 8徐建国.盐酸羟考酮的药理学和临床应用[J].临床麻醉学杂志,2014,30(5):511-513. 被引量:456
  • 9Lemberg KK, Heiskanen TE, Kontinen VK, et al. Pharma-cology of oxycodone: does it explain why oxycodone has be-come a bestselling strong opioid. Scand J Pain, 2009 * SI :S18-S23.
  • 10El-Shawarby S, MargaraR,TrewG, et al. A review of com-plications following transvaginal oocyte retrieval for in-vitrofertilization. Hum Fertil (Camb),2004, 7(2) : 127-133.

二级参考文献21

  • 1Pasternak GW.Molecular biology of opioid analgesia.J Pain Symptom Manage,2005,29(5 Suppl):S2-9.
  • 2Andreassen TN,Klepstad P,Davies A,et al.Is oxycodone efficacy reflected in serum concentrations? A multicenter,cross sectional study in 456 adult cancer patients.J Pain Symptom Manage,2012,43(4):694-705.
  • 3Staahl C,Dimcevski G,Andersen SD,et al.Different effect of opioids in patients with chronic pancrdatitis:an experimental pain study.Scand J Ganstroenterol,2007,42(3):383-390.
  • 4Davis MP,Varga J,Dickerson D,et al.Normal-release and controlled release oxycodone:pharmacokinetics,pharmacodynamics,and controversy.Support Care Cancer,2003,11(2):84-92.
  • 5King SJ,Reid C,Forbes K,et al.A systematic review of oxycodone in the management of cancer pain.Palliat Med,2011,25(5):454-470.
  • 6King S1,Forbes K,Hanks GW.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment:a European Palliative Care Research Collaborative opioid guidelines project.Palliat Med,2011,25(5):525-552.
  • 7Lazzari M,Sabato AF,Caldarulo C,et al.Effectiveness and tolerability of low dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain:an observational analysis.Curr Med Res Opin,2014,30(4):555-564.
  • 8McNicol ED,Midbari A,Eisenberg E.Opioids for neuropathic pain.Cochrane Database Syst Rev,2013,8:CD006146.
  • 9Lancaster T,McQuay H.Review:tricyclic antidepressants,capsaicin,gabapentin,and oxycodone are effective for postherpetic neuralgia.ACP J Club,2002,137(2):52.
  • 10de Beer Jde V,Winemaker MJ,Donnelly GA,et al.Efficacy and safety of controlled release oxycodone and standard therapies for postoperative pain after knee or hip replacement.Can J Surg,2005,48(4):277-283.

共引文献505

同被引文献78

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部